Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.0B
Avg Funding
$40.4M
Global Reach
7
countries

Top Cities for Therapeutics

Del Mar
Onalaska
Somerville
St Louis
New York
Birmingham

Recently Funded Companies

Export
Del Mar, United States

CeleCor Therapeutics develops first-point contact treatments for segment elevated myocardial infarction.

$11.9M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Onalaska, United States

Smart Infusion Therapy Services provides outpatient infusion therapy for chronic and complex medical conditions.

$500K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Somerville, United States

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.

$10.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

St Louis, United States

Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

$35.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Sharper Sense is a wearable patch that stimulates a neck nerve to improve hearing, vision, and touch.

$100K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Birmingham, United Kingdom

Healome Therapeutics is a healthcare company that develops treatments for ocular surface diseases.

$2.7M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

New York, United States

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

$125.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.

$37.7M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Bath, United Kingdom

Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.

$764K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

$15.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Exin Therapeutics offers next-gen neurotherapeutics leverage machine learning, genome editing, & bioelectronic medicine.

$500K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Noáin, Spain

Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.

$20.5M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Belfast, United Kingdom

Saltroad operates as a registered speech & language therapist based on child's speech.

$2.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

$32.8M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

$3.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

$8.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Medicenna is a clinical stage, privately held, immuno-oncology company.

$4.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Amsterdam, The Netherlands

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

$45.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

$59.2M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

$10.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Oakland, United States

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

$62.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Arlington, United States

Yutide Therapeutics is an animal health biotechnology company that develops therapeutics and antimicrobial peptides for companion animals.

$375K raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Chellaston, United Kingdom

Thalia Therapeutics is a drug reformulation company.

$3.6M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

$330.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

$190.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$40.4M
Total Funding Tracked
$1.0B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
3 companies$208.0M
2.New York
2 companies$125.1M
3.Cambridge
2 companies$18.5M
4.Del Mar
1 companies$11.9M
5.Onalaska
1 companies$500K

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,733 Therapeutics Startups (2026) — Recently Funded — Page 6 | VCBacked